Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.
Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check22 days agoChange DetectedThe website has been updated to version v2.11.0, with the previous version v2.10.5 removed, and a notice regarding delays in study record information has been deleted.SummaryDifference1%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.9%
- Check37 days agoChange DetectedRecent updates include new entries for September 2024, while previous updates from August 2024 have been removed.SummaryDifference0.6%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check58 days agoChange DetectedNew entries have been added for August 2024, while several January 2024 entries have been removed.SummaryDifference0.6%
Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.